Industry News

News image

Sanofi and Lead Pharma to develop treatments for autoimmune diseases

Sanofi announced today that it has entered into a research collaboration and license agreement with Dutch biot...

News image

Novo Nordisk and Karolinska Institutet join forces in the field of diabetes

Karolinska Institutet and Novo Nordisk today signed a collaboration agreement in the field of diabetes. The p...

News image

Duaklir® Genuair® approved in the European Union for chronic obstructive pulmonary disease

AstraZeneca today announced that Duaklir® Genuair® (aclidinium bromide/formoterol fumarate 340/12 mcg) has b...

News image

Merck lends support in the fight against Ebola

Merck, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and...

More in: Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Novo Nordisk, Novartis, Roche, Sanofi, Boehringer Ingelheim, Merck KGaA, Abbott, Nycomed, Schering-Plough, Merck, Genzyme, Lilly, Bristol-Myers Squibb, Shire, Amgen, UCB, Lundbeck

Friday, 27 February 2015   
Drug research and development more efficient than expected
Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could be responsible. To investigate the efficiency in the development of new drugs, the researchers analyzed a data set consisting of new drugs approved by the FDA. They looked at efficiency indicators that could potentially positively influence the approval of new drugs.
 
Wednesday, 25 February 2015   
Graphene shows potential as novel anti-cancer therapeutic strategy
University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells. This new development opens up the possibility of preventing or treating a broad range of cancers, using a non-toxic material. Writing in the journal Oncotarget, the team of researchers led by Professor Michael Lisanti and Dr Aravind Vijayaraghavan has shown that graphene oxide, a modified form of graphene, acts as an anti-cancer agent that selectively targets cancer stem cells (CSCs). In combination with existing treatments, this could eventually lead to tumour shrinkage as well as preventing the spread of cancer and its recurrence after treatment. However, more pre-clinical studies and extensive clinical trials will be necessary to move this forward into the clinic to ensure patient benefit.
 
Friday, 20 February 2015   
iManageCancer Survey: Your Opinion Counts
Would you like to contribute to the future of cancer treatment in technology? iManageCancer project is trying to find out how mobile healthcare (mHealth) and serious games might help people with chronic illnesses and in particular cancer. Significant improvements due to cancer research have led to more cancer patients being cured, and very many more enabled to live with their condition. The disease is now frequently managed as a chronic illness requiring long-term surveillance and, in some cases, maintenance treatment. As a chronic illness, however, there is an urgent need for patients and families to manage their own care.
 

Research & Development

Drug research and development more efficient than expected

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading...

Graphene shows potential as novel anti-cancer therapeutic strategy

University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells. This...

iManageCancer Survey: Your Opinion Counts

Would you like to contribute to the future of cancer treatment in technology? iManageCancer project is trying to find out...

New test to predict the effectiveness of cancer vaccines

Cancer vaccines are designed to turn the body's own immune system specifically against tumor cells. Particularly promising are vaccines that...

More in: Research & Development

Conferences & Events

mHealth Summit Europe 2015 and eHealth Week join forces

11 - 12 May 2015, Riga, Latvia. The mHealth Summit Europe will be back in 2015 as a part of eHealth Week in Riga, Latvia. The Summit will be opening...

European Telemedicine Conference 2014

7 - 8 October 2014, Rome, Italy. The European Telemedicine Conference (ETC) 2014 will combine the efforts of several leading European Healthcare Organisations into one powerful event. The conference will...

Medical Entrepreneur Start-up Hospital - M.E.S.H Camp 2014

17 - 18 September 2014, Berlin, Germany. Anyone who's ever tried to launch a start-up knows how hard it is. It takes all you've got to succeed. DocCheck Guano organises...

Biovision presents its selection of 44 promising life sciences businesses and projects

5 - 6 June 2014, Lyon, France. Biovision, the annual forum on future-oriented research in life sciences, today announces the list of biotech and medtech companies and projects selected for...

Delegates from more than 30 countries to share the benefits of eHealth at WoHIT 2014

2 - 4 April 2014, Nice, France. The World of Health IT Conference and Exhibition 2014 (WoHIT 2014), taking place in Nice, France, presents a comprehensive international programme with 18...

More in: Conferences & Events

EC Pharmaceuticals

Medicines for children: more research, more availability and more information compared with 5 years ago

News image

Recently, the Commission has publisheed a progress report on medicines for children covering the five years since the Paediatric Regulation came into force. This preliminary snapshot points to improvements in...

New symbol to identify medicines undergoing additional monitoring

News image

An inverted triangle will shortly appear on the inside leaflet of certain medicinal products on the EU market, following a legal act adopted by the European Commission today. The symbol...

Launch of EU Rapid Alert platform for human Tissues and Cells

News image

A secure alert platform launched by the European Commission will improve the safety of patients undergoing transplantation and medical procedures involving human tissues and cells, e.g. bone marrow, cornea, skin,...

Commission proposes faster access to medicines for patients

News image

Medicines should enter the market faster. With this intention the European Commission has proposed today to streamline and reduce the duration of national decisions on pricing and reimbursement of medicines....

Pricing and reimbursement of medicines: Commission consults on EU transparency rules

News image

The European Commission has launched a public consultation in view of modernising rules on the transparency of Member States’ decisions regarding the pricing and reimbursement of medicines. The consultation invites...

More in: European Commission

EMA News

Europe to boost cooperation with international partners on generics

News image

The European Union's decentralised procedure is being used as a model to accelerate the assessment of applications for generic medicines as part of the International Generic Drug Regulators Pilot(IGDRP). The...

European Medicines Agency recommends 39 medicines for human use for marketing authorisation in first half of 2014

News image

Thirty-nine medicines for human use were recommended for marketing authorisation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared...

EMA publishes 2013 annual report

News image

The European Medicines Agency (EMA) has published today its 2013 annual report. In 2013, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended 81 medicines for human use...

Committee for orphan medicines - overview of 2013 and looking ahead

News image

A total of 11 out of 81 medicines recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) in 2013 were intended...

More in: EMA